{"id":183453,"date":"2025-10-06T06:17:18","date_gmt":"2025-10-06T05:17:18","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/"},"modified":"2025-10-06T06:17:18","modified_gmt":"2025-10-06T05:17:18","slug":"tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/","title":{"rendered":"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg\" \/><\/p>\n<p>El Servicio de Hematolog\u00eda del <a href=\"https:\/\/www.hospitalsonespases.es\/ca\" target=\"_blank\" rel=\"noopener\">Hospital Universitario Son Espases<\/a> ha participado en la descripci\u00f3n de la experiencia real de GELTAMO sobre el uso del tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes.<\/p>","protected":false},"excerpt":{"rendered":"<p>El Servicio de Hematolog\u00eda del Hospital Universitario Son Espases ha participado en la descripci\u00f3n de la experiencia real de GELTAMO sobre el uso del tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-183453","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes\" \/>\n<meta property=\"og:description\" content=\"El Servicio de Hematolog\u00eda del Hospital Universitario Son Espases ha participado en la descripci\u00f3n de la experiencia real de GELTAMO sobre el uso del tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T05:17:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes\",\"datePublished\":\"2025-10-06T05:17:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/\"},\"wordCount\":60,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1137.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/\",\"name\":\"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1137.jpg\",\"datePublished\":\"2025-10-06T05:17:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1137.jpg\",\"contentUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1137.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/","og_locale":"es_ES","og_type":"article","og_title":"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes","og_description":"El Servicio de Hematolog\u00eda del Hospital Universitario Son Espases ha participado en la descripci\u00f3n de la experiencia real de GELTAMO sobre el uso del tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes.","og_url":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/","og_site_name":"bip4ex","article_published_time":"2025-10-06T05:17:18+00:00","og_image":[{"url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes","datePublished":"2025-10-06T05:17:18+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/"},"wordCount":60,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/","url":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/","name":"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg","datePublished":"2025-10-06T05:17:18+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#primaryimage","url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg","contentUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1137.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/tafasitamab-mas-lenalidomida-como-terapia-de-rescate-en-el-linfoma-difuso-de-celulas-b-grandes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Tafasitamab m\u00e1s lenalidomida como terapia de rescate en el linfoma difuso de c\u00e9lulas B grandes"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/183453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=183453"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/183453\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=183453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=183453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=183453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}